Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Guidance Priorities For FY 2022 Include Transitioning EUAs; List Includes CDS Software Again

Oct 26 2021

• By Ferdous Al-Faruque

Two lane road

Related Content

Industry Optimistic About Second CDS Draft Guidance; FDA Releases More Final Software Guidances

Sep 26 2019

Priority Lane: Guidances On Risky Devices, 510(k) Reform Top FDA’s To-Do List

Oct 16 2020

Additional Topics

United States FDA Guidance Documents Policy Regulation Digital Health Medical Device

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.